av/jubilant-life-sciences--big.svg

COM:JUBILANTPHARMOVA

Jubilant Pharmova

  • Stock

Last Close

1,138.50

25/11 04:20

Market Cap

115.38B

Beta: -

Volume Today

31.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
12.28B
-
12.88B
4.90%
12.26B
4.86%
12.18B
0.61%
13.06B
7.20%
14.04B
7.54%
16.31B
16.16%
14.87B
8.83%
11.92B
19.85%
13.18B
10.53%
average payables
8.87B
-
7.09B
20.12%
6.49B
8.36%
6.75B
3.88%
9.43B
39.77%
10.78B
14.35%
10.55B
2.13%
8.05B
23.68%
5.44B
32.44%
6.95B
27.64%
average receivables
10.44B
-
10.29B
1.46%
11.65B
13.28%
12.79B
9.74%
13.94B
9.05%
16.57B
18.83%
17.82B
7.54%
14.58B
18.21%
12.01B
17.57%
11.20B
6.80%
book value per share
164.90
-
154.04
6.59%
186.35
20.97%
220.44
18.30%
262.23
18.95%
308.54
17.66%
351.83
14.03%
297.71
15.38%
334.14
12.24%
339.12
1.49%
capex per share
-18.26
-
-23.55
28.96%
-22.79
3.21%
-29.78
30.68%
-31.38
5.38%
-42.08
34.09%
-36.05
14.34%
-33.12
8.12%
-37.69
13.81%
-51.15
35.71%
capex to depreciation
-1.03
-
-1.30
25.92%
-1.03
21.03%
-1.59
54.89%
-1.18
26.03%
-1.77
50.08%
-1.24
29.72%
-1.17
6.04%
-1.57
34.59%
-1.47
6.48%
capex to operating cash flow
-0.36
-
-0.48
32.15%
-0.33
31.96%
-0.37
12.33%
-0.38
2.56%
-0.58
55.84%
-0.37
36.38%
-0.30
20.55%
-0.72
142.31%
-1.23
72.08%
capex to revenue
-0.05
-
-0.06
27.74%
-0.06
3.86%
-0.08
28.98%
-0.07
18.19%
-0.07
10.68%
-0.06
12.27%
-0.09
38.28%
-0.10
11.95%
-0.13
32.25%
cash per share
29.93
-
24.54
18.01%
21.80
11.15%
29.92
37.23%
17.24
42.38%
88.34
412.46%
88.69
0.40%
43.04
51.48%
61.92
43.88%
71.81
15.97%
days of inventory on hand
182.22
-
154.50
15.21%
187.21
21.18%
197.79
5.65%
161.56
18.32%
135.39
16.20%
194.98
44.02%
235.09
20.57%
256.31
9.03%
268.32
4.69%
days payables outstanding
97.55
-
87.44
10.36%
92.32
5.57%
121.47
31.58%
131.92
8.61%
97.44
26.14%
115.20
18.22%
108.34
5.95%
115.96
7.03%
159.63
37.66%
days sales outstanding
65.27
-
65.35
0.12%
83.01
27.01%
79.84
3.82%
75.11
5.92%
72.47
3.52%
72.28
0.25%
69.61
3.70%
76.23
9.51%
57.16
25.02%
debt to assets
0.50
-
0.56
11.94%
0.50
9.08%
0.45
11.37%
0.36
19.39%
0.42
17.02%
0.38
9.02%
0.32
17.38%
0.32
0.70%
0.33
3.15%
debt to equity
1.67
-
1.95
16.74%
1.55
20.54%
1.18
24.16%
0.85
27.90%
1.01
18.58%
0.86
14.75%
0.60
30.45%
0.60
0.57%
0.68
13.46%
dividend yield
0.02
-
0.02
1.26%
0.01
60.41%
0.00
48.76%
0.00
5.29%
0.01
23.05%
0.04
637.19%
0.00
99.65%
0.01
9,429.04%
0.02
39.17%
earnings yield
0.04
-
-0.02
155.07%
0.07
379.51%
0.05
30.35%
0.05
5.44%
0.05
12.88%
0.23
311.75%
0.05
76.62%
0.07
26.65%
-0.01
121.81%
enterprise value
64.50B
-
68.38B
6.00%
106.85B
56.27%
160.60B
50.30%
164.32B
2.32%
142.93B
13.02%
75.52B
47.16%
131.79B
74.51%
83.90B
36.34%
71.03B
15.35%
enterprise value over ebitda
6.40
-
10.02
56.67%
8.45
15.66%
12.02
42.20%
10.72
10.81%
8.05
24.88%
3.81
52.69%
8.66
127.44%
7.27
16.06%
8.59
18.11%
ev to operating cash flow
8.04
-
8.73
8.62%
9.78
12.05%
12.66
29.43%
12.61
0.41%
12.74
1.07%
4.89
61.59%
7.39
50.90%
10.02
35.62%
10.75
7.32%
ev to sales
1.13
-
1.18
5.00%
1.87
58.34%
2.79
48.61%
2.21
20.55%
1.59
28.22%
0.84
47.04%
2.21
162.66%
1.38
37.34%
1.14
17.52%
free cash flow per share
32.13
-
25.63
20.24%
47.17
84.03%
51.60
9.40%
52.24
1.24%
29.87
42.82%
60.82
103.62%
78.91
29.74%
14.92
81.09%
-9.66
164.72%
free cash flow yield
0.20
-
0.17
17.08%
0.11
32.50%
0.06
42.98%
0.06
4.42%
0.04
27.77%
0.24
447.94%
0.12
52.53%
0.04
66.81%
-0.03
190.09%
graham net net
-261.26
-
-275.90
5.60%
-263.66
4.44%
-232.34
11.88%
-222.81
4.10%
-207.50
6.87%
-203.99
1.69%
-130.19
36.18%
-132.71
1.94%
-201.04
51.49%
graham number
159.37
-
112.11
29.65%
340.39
203.62%
428.00
25.74%
493.32
15.26%
505.83
2.54%
668.15
32.09%
491.28
26.47%
442.16
10.00%
176.33
60.12%
income quality
3.87
-
19.42
401.65%
1.87
90.38%
1.72
8.01%
1.52
11.79%
1.24
18.20%
1.27
2.72%
1.47
15.50%
1.33
9.76%
23.78
1,690.17%
intangibles to total assets
0.26
-
0.27
1.88%
0.27
1.30%
0.27
0.49%
0.27
2.08%
0.23
13.44%
0.23
2.94%
0.33
45.87%
0.32
3.47%
0.30
4.50%
interest coverage
2.38
-
1.23
48.20%
2.75
123.24%
3.57
29.84%
4.19
17.44%
6.71
60.10%
5.58
16.88%
6.17
10.64%
5.58
9.49%
1.45
74.04%
interest debt per share
295.18
-
321.45
8.90%
311.20
3.19%
278.83
10.40%
239.55
14.09%
323.78
35.16%
319.01
1.47%
188.55
40.90%
209.22
10.96%
242.75
16.03%
inventory turnover
2.00
-
2.36
17.94%
1.95
17.48%
1.85
5.34%
2.26
22.42%
2.70
19.33%
1.87
30.56%
1.55
17.06%
1.42
8.28%
1.36
4.48%
invested capital
1.67
-
1.95
16.74%
1.55
20.54%
1.18
24.16%
0.85
27.90%
1.01
18.58%
0.86
14.75%
0.60
30.45%
0.60
0.57%
0.68
13.46%
market cap
25.32B
-
24.35B
3.81%
65.09B
167.25%
124.66B
91.54%
132.02B
5.90%
104.52B
20.83%
39.69B
62.02%
108.48B
173.29%
61.78B
43.04%
44.40B
28.14%
net current asset value
-31.48B
-
-34.51B
9.62%
-31.36B
9.12%
-26.96B
14.04%
-23.93B
11.24%
-20.75B
13.30%
-18.79B
9.41%
-12.24B
34.87%
-11.65B
4.80%
-20.02B
71.84%
net debt to ebitda
3.89
-
6.45
66.04%
3.30
48.80%
2.69
18.59%
2.11
21.65%
2.16
2.70%
1.81
16.48%
1.53
15.19%
1.92
25.08%
3.22
67.98%
net income per share
6.85
-
-3.63
152.98%
27.63
862.01%
36.93
33.64%
41.25
11.69%
36.86
10.65%
56.39
53.01%
36.03
36.11%
26.01
27.83%
-4.07
115.67%
operating cash flow per share
50.39
-
49.17
2.41%
69.96
42.26%
81.38
16.33%
83.62
2.76%
71.95
13.95%
96.87
34.63%
112.03
15.65%
52.62
53.03%
41.50
21.14%
payables turnover
3.74
-
4.17
11.56%
3.95
5.28%
3.00
24.00%
2.77
7.93%
3.75
35.39%
3.17
15.41%
3.37
6.33%
3.15
6.57%
2.29
27.36%
receivables turnover
5.59
-
5.59
0.12%
4.40
21.27%
4.57
3.97%
4.86
6.29%
5.04
3.65%
5.05
0.25%
5.24
3.84%
4.79
8.68%
6.39
33.36%
research and ddevelopement to revenue
return on tangible assets
0.02
-
-0.01
154.75%
0.07
824.16%
0.09
32.27%
0.09
4.15%
0.07
28.57%
0.09
41.95%
0.10
3.51%
0.06
36.69%
-0.01
113.75%
revenue per share
359.21
-
362.64
0.95%
365.09
0.68%
369.88
1.31%
476.43
28.81%
577.24
21.16%
563.57
2.37%
374.46
33.56%
380.66
1.66%
390.62
2.62%
roe
0.04
-
-0.02
156.71%
0.15
729.90%
0.17
12.97%
0.16
6.11%
0.12
24.06%
0.16
34.18%
0.12
24.49%
0.08
35.69%
-0.01
115.44%
roic
0.07
-
-0.06
180.33%
0.09
269.13%
0.11
19.44%
0.11
3.29%
0.09
15.52%
0.11
16.75%
0.09
15.38%
0.06
36.07%
-0.07
218.33%
sales general and administrative to revenue
0.02
-
0.02
15.88%
0.02
20.35%
0.02
4.16%
0.02
10.72%
0.03
51.34%
0.03
7.68%
0.04
41.84%
0.04
4.16%
0.04
11.58%
shareholders equity per share
164.90
-
154.04
6.59%
186.35
20.97%
220.44
18.30%
262.23
18.95%
308.54
17.66%
351.83
14.03%
297.71
15.38%
334.14
12.24%
339.12
1.49%
stock based compensation to revenue
0.00
-
0.00
216.37%
tangible asset value
4.45B
-
1.31B
70.49%
4.71B
259.07%
9.21B
95.38%
14.56B
58.11%
21.47B
47.45%
27.83B
29.62%
18.11B
34.93%
21.47B
18.57%
20.12B
6.29%
tangible book value per share
27.93
-
8.24
70.49%
30.19
266.30%
59.08
95.72%
93.43
58.14%
137.75
47.43%
174.73
26.84%
113.71
34.92%
134.90
18.64%
126.38
6.32%
working capital
-9.63B
-
5.85B
160.78%
3.87B
33.92%
12.72B
228.87%
11.85B
6.85%
24.95B
110.54%
24.19B
3.04%
19.04B
21.31%
19.18B
0.73%
19.90B
3.78%

All numbers in (except ratios and percentages)